Aridis Provides Corporate Update

2 years ago

LOS GATOS, Calif., March 31, 2023 (GLOBE NEWSWIRE) -- Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS) (“Aridis” or the “Company”), a biopharmaceutical…

ABVC BioPharma Announces Fiscal Year 2022 Financial and Operational Results

2 years ago

FREMONT, CA, March 31, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- ABVC BioPharma, Inc. (Nasdaq: ABVC), a biotechnology company specializing…

NuGen Medical to Raise Up to $3.6 Million in Non-Brokered Private Placement

2 years ago

Toronto, Ontario--(Newsfile Corp. - March 31, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") announces it…

Satellos Bioscience Announces 2022 Year End Financial Results and Operational Highlights

2 years ago

Toronto, Ontario--(Newsfile Corp. - March 30, 2023) - Satellos Bioscience Inc. (TSXV: MSCL) (OTCQB: MSCLF) ("Satellos" or the "Company"), a…

StageZero to Issue Q4 2022 Financial Results on Friday March 31

2 years ago

Toronto, Ontario--(Newsfile Corp. - March 30, 2023) - StageZero Life Sciences (TSX: SZLS) ("StageZero" or the "Company") today announced that…

Shepherd Premier Senior Living Launches Boutique Senior Living Niche to Revolutionize the Senior Care Industry

2 years ago

Crystal Lake, Illinois--(Newsfile Corp. - March 30, 2023) - A unique and largely unknown niche is being launched by Shepherd…

<div>Bell Buckle’s JUMP START SPORTS Announces OHIO Territory Expansion</div>

2 years ago

Naples, Florida--(Newsfile Corp. - March 30, 2023) - Bell Buckle Holdings, Inc. (OTC Pink: BLLB) subsidiary Jump Start Sports announces…

NervGen Pharma Reports 2022 Year End Results and Provides Operational Update Including Plans to Initiate Phase 1b/2a Clinical Trial of Proprietary NVG-291 in Q3 2023

2 years ago

Equity proceeds of CA$22M+ raised during 2022 fiscal yearPhase 1 clinical trial dosing of proprietary compound, NVG-291, is complete and…

StageZero to Issue Q4 2022 Financial Results and Hold Conference Call on Thursday March 30

2 years ago

Toronto, Ontario--(Newsfile Corp. - March 29, 2023) - StageZero Life Sciences (TSX: SZLS) ("StageZero" or the "Company") today announced that…

Satellos Bioscience Announces Closing of Previously Announced Non-Brokered Offering of $2.385 Million of Unsecured Non-Convertible Debentures

2 years ago

Toronto, Ontario--(Newsfile Corp. - March 29, 2023) - Satellos Bioscience Inc. (TSXV: MSCL) (OTCQB: MSCLF) ("Satellos" or the "Company"), a…